A Quick Look at Today's Ratings for Novocure(NVCR.US), With a Forecast Between $30 to $40

Futu NewsDec 3 21:00 · Ratings

Zai Lab, Novocure Announce PANOVA-3 Trial Met Primary Endpoint

Yahoo FinanceDec 3 20:17

U.S. Small Caps Close Mixed As Novocure Lead, Archer Aviation Lags

Dow JonesDec 3 05:20

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 3 05:05

Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates

BenzingaDec 3 01:44

Positive Outlook for NovoCure: Buy Rating Backed by Successful PANOVA-3 Trial and Promising Market Potential

TipRanksDec 3 00:55 · Ratings